Background: Despite a large measles outbreak is taking place in WHO European region, currently no data are available on measles immunization coverage in the asylum seeker and migrants hosted in this area. Methods: Two hundred and fifty-six migrants upon their arrival in Italy on March, April and May 2016 were screened for measles virus IgG antibodies by chemiluminescence immunoassay (Liaison XL analyzer, Diasorin, Italy). The virus susceptibility in this cohort, the differences between the official country reported and the observed measles immunization coverage and the impact of current measles outbreak on the asylum seekers hosted in the largest Asylum Seeker centres of Italy, were evaluated. Results: The prevalence of subjects with positive result for measles IgG antibodies ranged between 79.9% and 100%. In Senegal, Mali, Nigeria, Pakistan and Bangladesh, the measles IgG seroprevalence observed was greater than the vaccinal coverage reported by WHO after I dose of vaccine. Based on data regarding the II dose coverage, the ASs population presented a seroprevalence greater to that expected. Conclusion: On the basis of the results obtained, extraordinary screening and vaccination campaigns in the migrant population, especially in the course of large outbreaks, could represent a resource to reach an adequate measles immunization coverage and to control this infectious disease.
Introduction
Currently a measles outbreak is taking place in Italy. From January to April 2017, 1 920 measles cases were reported in Italy rising more than fivefold compared to the same month last year, in accordance with the data of the National Health Institute. 1 Measles is among the most contagious viral diseases known, in fact a single person with measles infects an average of [12] [13] [14] [15] [16] [17] [18] people in a fully susceptible population. This is a basic reproductive rate (R 0 ) that is much higher in comparison with Ebola with 1.5-2.5 or Influenza with 1.4-4. [2] [3] [4] It may lead to serious complications including pneumonia and encephalitis and may lead to death. 2, 5 Currently there are no available data on the impact of this outbreak on immigrant populations in WHO European Region; likewise, the possible implications in terms of public health due to the levels of vaccine coverage of migrants are not known. Currently, WHO reports are focused only on data about the immunization coverage consequent to vaccination campaigns. The levels of immunization coverage reported by WHO are not adequate because often lower the 95% recommended to guarantee the optimal population protection. (http://apps.who.int/gho/data/node.wrapper.immunizationcov?x-country=ERI).
In this study, we evaluated (i) the measles IgG seroprevalences in a group of migrants coming from different African and Asian regions to better understand their immunization coverage, (ii) the differences between the official country reported and the observed measles immunization coverage, (iii) the impact of current Italian measles outbreak on the asylum seekers (ASs) hosted in the Asylum Seeker centres (ASCs) of Castelnuovo di Porto (Rome, Italy).
Materials and Methods
The ASC of Castelnuovo di Porto currently host 944 ASs and since January 2017 more than 2000 migrants have stayed there. It has an outpatient internal healthcare facility (IHF) devoted to the protection of migrant health. The clinic was led by consultant physicians accredited in internal medicine and infectious diseases. The team also included six nurses, four psychologists and six cultural mediators. The clinic is open 24 h on 24 h, 7 days a week.
The health management strategy of individual people and public health is based on a screening visit on arrival. After the first visit, the access to medical care for asylum seekers was mainly linked to the presence of clinical symptoms. Patients with chronic or acute illnesses are continuously followed by medical equipe on the basis of the guidelines for the management of different pathologies.
The first clinical screening evaluation, performed on arrival at the ASC, was based on (i) sociodemographic, epidemiological and anamnestic data collection on patient medical records; (ii) physical examination; (iii) blood test including haematology and biochemistry tests; (iv) microbiological surveillance, exanthematic illnesses and transmissible diseases (also Sexual Transmitted Infections) screening. Blood tests, urine analysis, microbiological cultures, virologic assays and radiological features were made in convention with laboratories affiliated with the National Health Service.
Moreover, mandatory and volunteer vaccination programs are active for paediatric and adult population. All migrants arrived at the ASCs are subjected to anti-polio vaccination and vulnerable people even flu, pneumococcal and hepatitis B vaccination. [6] [7] [8] In this study, a population of ASs,upon their arrival in Italy on March, April and May 2016 were screened for measles virus IgG antibodies to evaluate the virus susceptibility in this cohort. Serum measles virus IgG antibodies were measured by chemiluminescence immunoassay using Liaison Measles IgG Kit (Liaison XL analyzer, Diasorin, Italy).
A compatible clinical syndrome is defined by the presence of characteristic measles clinical symptoms (i.e. fever, coryza, rash) possibly linked to a laboratory-confirmed case. The case definition is based on laboratory confirmation with positive serologic test for measles specific IgM antibody or polymerase chain reaction (PCR). 9 
Results
The population studied was composed of 256 ASs from Africa (134 Eritrean and 80 from west area, including 25 Malians, 23 Gambians, 17 Senegalese and 15 Nigerians) and 42 from Asia (27 from Pakistan and 15 from Bangladesh). About 82.8% of the subjects examined were males.
The median age registered was 24 years old (min 18, max 60). No significant differences in term of age were observed between groups of different nationalities.
The prevalence of subjects with positive result for measles IgG antibodies observed are showed in Table 1 and ranged from 79.9% to 100%.
The difference between the prevalence of subjects with measles IgG antibodies observed in the study population and the most recent immunization levels (WHO, year 2016) due to the vaccinal procedures in different countries studied are depicted in Figure 1A . In Senegal, Mali, Nigeria, Pakistan and Bangladesh, the measles IgG seroprevalence observed was greater than the vaccinal coverage reported by WHO after I dose of vaccine (http://apps.who.int/gho/data/node.wrapper.immunization-cov? x-country=ERI). Based upon II dose vaccine coverage, the group of ASs enroled in the study from each country, presented a seroprevalence greater to that expected. Figure 1B shows the delta between annual official country measles immunization coverage reported by WHO and observed seroprevalence in ASs population. Since 1993, the immunization 
Discussion
In 2017 measles outbreaks continues to spread within and among the WHO European Region, wherever immunization coverage has dropped below the necessary threshold of 95%. 10 In this context, European countries are currently experiencing an unprecedented influx of refugees, ASs and other migrants. Italy has announced a new record of 181 000 migrants crossing the Mediterranean in 2016, they come mostly from Africa, with the top three nationality Nigerian, Eritrean and Guinean. 11 Despite vaccination efforts, both through campaigns and routine immunization, resulting in a reduction of 92% of measles cases during 2000-2008 in the WHO African region, most of the countries of Central and West Africa have immunized only about 80% or less of their populations, when the WHO recommendation is to reach 95%. 12 Moreover, despite two doses of the vaccine are recommended to ensure immunity, a significant quote of vaccinated subjects receive only the first dose in the WHO African and South East Asian region: as about 15% of vaccinated children fail to develop immunity from the first dose, the implication is that the real vaccine coverage could be less effective than that reported. 13 On the other hand, measles vaccination coverage can be boosted as an effect of increased antibody titre observed after subclinical measles in vaccinated subjects.
14 Our data reported the prevalence of positivity for measles virus IgG antibodies in the most represented migrant groups present in Italy: an adequate immunization coverage was observed only for people from South East Asian region, whereas all African countries examined showed suboptimal measles IgG seroprevalences, ranging from 79.9% to 93.3%. Obviously, these data are not only the expression of measles vaccine coverages, but also the results of recent and past outbreaks that occurred in migrants' home countries. For example, Senegal experienced a large measles outbreak in 2009, Nigeria in 2008 and 2011 (with more than 28 800 new cases reported), and a measles outbreak involving migrants of Eritrean and Sudanese origin was described in Israel in 2012. Moreover, Sub-Saharan Africa measles incidence was 125/1 000 000 in 2012 and Nigeria ranks top among countries with endemic transmission of measles infection yearly in WHO African region. [15] [16] [17] [18] [20] [21] [22] In cases of countries with low immunization coverage reported by WHO and high IgG seroprevalence detected in the study, such as Nigeria and Pakistan, the differences could be due to the recurrent epidemic waves observed through the years. Coversely, in case of countries with high reported levels immunization coverage after the I dose of vaccine and lower IgG seroprevalence, as in Gambia, it has to be remembered that real vaccinal coverage is reached only after the II dose of vaccine. The significant differences between the prevalence of measles IgG antibodies observed in this study, the immunization levels due to the vaccinal programs in different countries reported by WHO, and the official country reported measles immunization coverage, could reflect some difference between the population enroled in the ASC and the population resident in the homeland (i.e. median age, sex, source area, education, access to health resources, etc). Moreover, WHO and government data were generally based on estimated resources, but achieved in population studies; otherwise our report was based on measured data, but obtained in a less large selected sample of migrants (ASs). The potential bias in the enrolment could explains the difference observed.
A zero measles infections rate between ASs resident in ASC of Castelnuovo di Porto in course of a large outbreak in hosting country (favoured by an inadequate immunization coverage), could be explained by the fact that the reception centre is an enclave. In this geographical space takes place most of the life of migrants and therefore the opportunities for contact with the autochthone resident population are substantially reduced.
The knowledge of the level of migrant immunization coverage is one of the key topics to establish prevention policies and limit the risk of outbreaks in host countries. In fact, outbreaks associated with the introduction of viral strains, specific of the areas of origin of migrants, are possible and have been well described. For example, the analysis of the sequence obtained from measles cases in the United States from 1997 to 2001, indicated the presence of different genotypes including a number of viruses belonging to genotype D4 imported from Pakistan and India. 23 On the other hand, the B3 genotype is endemic in Sub- 
Conclusion
Although a universal screening for all refugees could be indicated, it is more conceivable to perform a screening devoted just to subjects coming from countries with low II dose vaccine coverage or in case of absence of data about the II dose administration. This strategy could be recommended for all the European ASC taking into account the policy for European relocation programmes of ASs to avoid possible outbreaks.
